JFGIW
MYGN icon

Johnson Financial Group Inc (Wisconsin)’s Myriad Genetics MYGN Stock Holding History

Johnson Financial Group Inc (Wisconsin)’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-36
Closed -$881 – 1000
2024
Q2 		$881 Buy
+36
New +$790 ﹤0.01% 754
2014
Q1 		– Sell
-3,625
Closed -$76K – 721
2013
Q4 		$76K Hold
3,625
– – 0.02% 315
2013
Q3 		$85K Sell
3,625
-1,100
-23% -$31.3K 0.03% 329
2013
Q2 		$127K Buy
+4,725
New +$137K 0.04% 284

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Johnson Financial Group Inc (Wisconsin)'s MYGN Position: Q3 2024 in Review

Johnson Financial Group Inc (Wisconsin) sold out of Myriad Genetics (MYGN) in Q3 2024, closing a stake of 36 shares — an estimated $881 sold.

Johnson Financial Group Inc (Wisconsin) first reported a position in MYGN in Q2 2013 and held it in 4 quarters. The position peaked at $127K in Q2 2013. 246 funds tracked by Wall St. Rank hold MYGN as of Q3 2024.

  • Johnson Financial Group Inc (Wisconsin) reported no remaining Myriad Genetics position as of Q3 2024 after selling out during the quarter.
  • Johnson Financial Group Inc (Wisconsin) sold 36 Myriad Genetics shares in Q3 2024, an estimated $881.
  • Johnson Financial Group Inc (Wisconsin) first reported a position in Myriad Genetics in Q2 2013 and held it in 4 quarters.
  • Johnson Financial Group Inc (Wisconsin)'s Myriad Genetics position peaked at $127K in Q2 2013.
  • 246 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2024.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q3 2024, filed 13 Nov 2024.